CBA Florida Inc. (fka CBAI)

[Dew]

Damn. You may be correct. Here is what I found on Osiris. And they are partnered with Genzyme Corporation. Hmmm. A new name.

http://investor.osiris.com/


Prochymal is being evaluated in Phase III clinical trials for three indications, including steroid refractory acute graft versus host disease (GvHD), newly diagnosed acute GvHD and also Crohn's disease, and is the only stem cell therapeutic currently designated by the FDA as both an Orphan Drug and Fast Track product.

Prochymal is also being developed for the repair of heart tissue following a heart attack, the protection of pancreatic islet cells in patients with type 1 diabetes, and the repair of lung tissue in patients with pulmonary disease.

Osiris has partnered with Genzyme Corporation to develop Prochymal as a medical countermeasure to nuclear terrorism and other radiological emergencies.